Suresh Ramalingam, MD, a medical oncologist at the Winship Cancer Institute of Emory University, has been awarded a National Cancer Institute Clinical Investigator Team Leadership Award. The award includes a two-year, $100,000 grant.
The Clinical Investigator Team Leadership Award recognizes clinical investigators at NCI designated cancer centers who provide critical leadership and support for institutional and multi-center clinical trials. NCI provides the award to support, acknowledge and recognize outstanding clinical investigators whose participation and activities promote successful clinical research programs and to promote retention of clinical investigators in an academic career in clinical research.
Ramalingam is an associate professor of hematology and medical oncology at Emory and director of Winship’s Translational Thoracic Malignancies Program. He also is a Georgia Cancer Coalition Distinguished Cancer Clinician and Scientist.
“We are immensely proud of this major recognition of Dr. Ramalingam’s work,” says Fadlo Khuri, MD, chair of the Department of Hematology and Medical Oncology at Emory. “This is well-deserved recognition by the NCI of Dr. Ramalingam, who is a superb investigator as well as a caring and thoughtful clinician.”
Ramalingam serves as the principal investigator on several lung cancer clinical trials, many of which are sponsored by the NCI. He is widely published in peer-reviewed scientific journals and serves as a reviewer for a number of medical journals. Ramalingam is the Co-chair of the Thoracic Core Committee of the Eastern Cooperative Oncology Group and serves on the editorial board of the journals Cancer, Clinical Lung Cancer and Cancer, Chemotherapy and Pharmacology.
Ramalingam earned his medical degree at the University of Madras in India, and served as chief medical resident in Internal Medicine at Wayne State University in Detroit. He conducted his fellowship in hematology and oncology at the University of Pittsburgh.
